|
Volumn 66, Issue 5, 2009, Pages 663-666
|
Hashimoto encephalopathy and down syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
C REACTIVE PROTEIN;
CORTICOSTEROID;
CYANOCOBALAMIN;
GLUCOSE;
METHYLPREDNISOLONE;
PREDNISOLONE;
PROTEIN;
RISPERIDONE;
THYROTROPIN;
THYROXINE;
VALPROIC ACID;
VENLAFAXINE;
ADD ON THERAPY;
ADULT;
ALZHEIMER DISEASE;
ANXIETY DISORDER;
ARTICLE;
BEHAVIOR CHANGE;
BLOOD ANALYSIS;
BRACHYCEPHALY;
BRADYPHRENIA;
CASE REPORT;
CEREBROSPINAL FLUID;
CLINICAL STUDY;
COGNITIVE DEFECT;
COMPUTER ASSISTED TOMOGRAPHY;
CONGENITAL HYPOTHYROIDISM;
DEPRESSION;
DOWN SYNDROME;
DROWSINESS;
DRUG MEGADOSE;
ELECTROENCEPHALOGRAPHY;
EPILEPTIC STATE;
ERYTHROCYTE;
FEMALE;
FOLLOW UP;
FREE LIOTHYRONINE INDEX;
FREE THYROXINE INDEX;
FUNCTIONAL DISEASE;
GLASGOW COMA SCALE;
HASHIMOTO DISEASE;
HASHIMOTO ENCEPHALOPATHY;
HEART RATE;
HERPES SIMPLEX VIRUS;
HUMAN;
HYPERREFLEXIA;
HYPOTHYROIDISM;
LOW DRUG DOSE;
LUMBAR PUNCTURE;
LYMPHOCYTE;
MAINTENANCE THERAPY;
MENTAL DETERIORATION;
MENTAL DISEASE;
MUSCLE HYPERTONIA;
MUSCLE TWITCH;
MYOCLONUS;
NEUROLOGIC EXAMINATION;
NOSE FEEDING;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OUTCOME ASSESSMENT;
PHYSIOTHERAPY;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PSYCHOSIS;
SOMNOLENCE;
THYROID FUNCTION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
VISUAL HALLUCINATION;
VITAMIN BLOOD LEVEL;
WALKING DIFFICULTY;
WEAKNESS;
ADRENAL CORTEX HORMONES;
BRAIN;
BRAIN DISEASES, METABOLIC;
COMORBIDITY;
DISEASE PROGRESSION;
DOWN SYNDROME;
ELECTROENCEPHALOGRAPHY;
FEMALE;
GENETIC PREDISPOSITION TO DISEASE;
HASHIMOTO DISEASE;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MIDDLE AGED;
THYROID GLAND;
THYROID HORMONES;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 66249109241
PISSN: 00039942
EISSN: 15383687
Source Type: Journal
DOI: 10.1001/archneurol.2009.45 Document Type: Article |
Times cited : (21)
|
References (14)
|